Pages that link to "Q67465568"

The following pages link to Immunohistochemical evidence of the existence and localization of aromatase in human prostatic tissues (Q67465568):

Displaying 18 items.

• Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat (Q24561881) (← links)
• Selective androgen receptor modulators in preclinical and clinical development (Q24645579) (← links)
• Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation (Q24815477) (← links)
• Dual effects of phytoestrogens result in u-shaped dose-response curves (Q24817159) (← links)
• Age-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progression (Q27027373) (← links)
• Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life (Q28505915) (← links)
• Estrogens in Male Physiology (Q30090708) (← links)
• Prostate phenotypes in estrogen-modulated transgenic mice. (Q34594281) (← links)
• The role of estrogens and estrogen receptors in normal prostate growth and disease (Q36488068) (← links)
• Oxytocin and the human prostate in health and disease (Q36921752) (← links)
• Estrogen and androgen signaling in the pathogenesis of BPH. (Q37828063) (← links)
• Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. (Q39700571) (← links)
• Transdermal Dihydrotestosterone Treatment of 'Andropause' (Q40488399) (← links)
• Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study (Q41991645) (← links)
• Aromatase immunolocalization in human ductuli efferentes and proximal ductus epididymis (Q47920550) (← links)
• Inhibition of 5 α-reductase and aromatase by PHL-00801 (Prostatonin®), a combination of PY102 (Pygeum africanum) and UR102 (Urtica dioica) extracts (Q56765408) (← links)
• Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: changes in prostate volume and histopathological findings (Q71022059) (← links)
• Equine cytochrome P450 aromatase exhibits an estrogen 2-hydroxylase activity in vitro (Q73014451) (← links)